OpenURL Connection Search

Select item for more details and to access through your institution.

Advances in Therapy for Relapsed or Refractory Hodgkin Lymphoma.
Published in:
Current Oncology Reports, 2020, v. 22, n. 1, p. 1, doi. 10.1007/s11912-020-0866-3
By:
- Choi, Yun;
- Diefenbach, Catherine S.
Publication type:
Article
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas.
Published in:
British Journal of Haematology, 2024, v. 204, n. 5, p. 1762, doi. 10.1111/bjh.19419
By:
- Soumerai, Jacob D.;
- Diefenbach, Catherine S.;
- Jagadeesh, Deepa;
- Asch, Adam;
- Kumar, Abhijeet;
- Tsai, Michaela L.;
- Jandl, Thomas A.;
- Lossos, Izidore S.;
- Kenkre, Vaishalee P.;
- Awan, Farrukh;
- Novotny, William;
- Huang, Jane;
- Miao, Lu;
- Rajagopalan, Prabhu;
- Ghalie, Richard G.;
- Zelenetz, Andrew D.
Publication type:
Article
Potentially inappropriate medication use in elderly non‐Hodgkin lymphoma patients is associated with reduced survival and increased toxicities.
Published in:
British Journal of Haematology, 2018, v. 180, n. 2, p. 267, doi. 10.1111/bjh.15027
By:
- Lin, Richard J.;
- Ma, Helen;
- Guo, Robin;
- Troxel, Andrea B.;
- Diefenbach, Catherine S.
Publication type:
Article
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
Published in:
British Journal of Haematology, 2015, v. 171, n. 4, p. 530, doi. 10.1111/bjh.13634
By:
- Diefenbach, Catherine S.;
- Li, Hailun;
- Hong, Fangxin;
- Gordon, Leo I.;
- Fisher, Richard I.;
- Bartlett, Nancy L.;
- Crump, Michael;
- Gascoyne, Randy D.;
- Wagner, Henry;
- Stiff, Patrick J.;
- Cheson, Bruce D.;
- Stewart, Douglas A.;
- Kahl, Brad S.;
- Friedberg, Jonathan W.;
- Blum, Kristie A.;
- Habermann, Thomas M.;
- Tuscano, Joseph M.;
- Hoppe, Richard T.;
- Horning, Sandra J.;
- Advani, Ranjana H.
Publication type:
Article
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study.
Published in:
American Journal of Hematology, 2022, v. 97, n. 1, p. E24, doi. 10.1002/ajh.26400
By:
- Phillips, Tycel;
- Brunvand, Mark;
- Chen, Andy I.;
- Essell, James;
- Chiappella, Annalisa;
- Diefenbach, Catherine;
- Cheng, Ji;
- Ramies, David;
- Hirata, Jamie;
- Morschhauser, Franck;
- Flinn, Ian W.
Publication type:
Article
Checkpoint Inhibition in Hodgkin Lymphoma: Saving the Best for Last?
Published in:
Oncology (08909091), 2016, v. 30, n. 10, p. 914
By:
- Lin, Richard J.;
- Diefenbach, Catherine S.
Publication type:
Article
Peripheral T-Cell Lymphoma: Time for a T-Cell-Centric Standard of Care.
Published in:
Oncology (08909091), 2013, v. 27, n. 9, p. 885
By:
- FLEUR-LOMINY, SHELLA SAINT;
- DIEFENBACH, CATHERINE S.
Publication type:
Article
Laboratory Workup of Lymphoma in Adults.
Published in:
2021
By:
- Kroft, Steven H;
- Sever, Cordelia E;
- Bagg, Adam;
- Billman, Brooke;
- Diefenbach, Catherine;
- Dorfman, David M;
- Finn, William G;
- Gratzinger, Dita A;
- Gregg, Patricia A;
- Leonard, John P;
- Smith, Sonali;
- Souter, Lesley;
- Weiss, Ronald L;
- Ventura, Christina B;
- Cheung, Matthew C
Publication type:
journal article
Immune targeting of the microenvironment in classical Hodgkin's lymphoma: insights for the hematologist.
Published in:
Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719846451
By:
- Carreau, Nicole A.;
- Diefenbach, Catherine S.
Publication type:
Article
Lysophosphatidic acid acyltransferase‐β (LPAAT‐β) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival.
Published in:
Cancer (0008543X), 2006, v. 107, n. 7, p. 1511
By:
- Catherine S.M. Diefenbach;
- Robert A. Soslow;
- Alexia Iasonos;
- Irina Linkov;
- Cyrus Hedvat;
- Lynn Bonham;
- Jack Singer;
- Richard R. Barakat;
- Carol Aghajanian;
- Jakob Dupont
Publication type:
Article
IBCL-373: Updated Experience from Mosunetuzumab in Multiple Relapsed Follicular Lymphoma: Promising Efficacy from a Phase I Trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S406, doi. 10.1016/S2152-2650(21)01916-9
By:
- Assouline, Sarit;
- Won Seog Kim;
- Sehn, Laurie H.;
- Schuster, Stephen J.;
- Chan Yoon Cheah;
- Nastoupil, Loretta J.;
- Shadman, Mazyar;
- Sung-Soo Yoon;
- Matasar, Matthew J.;
- Diefenbach, Catherine;
- Gregory, Gareth P.;
- Bartlett, Nancy L.;
- Wei, Michael C.;
- Doral, Michelle Y.;
- Shen Yin;
- Negricea, Raluca;
- Chi-Chung Li;
- Penuel, Elicia;
- Huang Huang;
- Budde, L. Elizabeth
Publication type:
Article
ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S393, doi. 10.1016/S2152-2650(21)01892-9
By:
- Budde, Elizabeth;
- Ghosh, Nilanjan;
- Chavez, Julio;
- Lossos, Izidore S.;
- Mehta, Amitkumar;
- Dorritie, Kathleen;
- Kamdar, Manali;
- Negricea, Raluca;
- Song Pham;
- Hristopoulos, Maria;
- Ling-Yuh Huw;
- OHear, Carol;
- Yasuhiro Oki;
- To, Iris;
- Diefenbach, Catherine
Publication type:
Article
Poster: IBCL-373: Updated Experience from Mosunetuzumab in Multiple Relapsed Follicular Lymphoma: Promising Efficacy from a Phase I Trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S245, doi. 10.1016/S2152-2650(21)01540-8
By:
- Assouline, Sarit;
- Kim, Won Seog;
- Sehn, Laurie H.;
- Schuster, Stephen J.;
- Cheah, Chan Yoon;
- Nastoupil, Loretta J.;
- Shadman, Mazyar;
- Yoon, Sung-Soo;
- Matasar, Matthew J.;
- Diefenbach, Catherine;
- Gregory, Gareth P.;
- Bartlett, Nancy L.;
- Wei, Michael C.;
- Doral, Michelle Y.;
- Yin, Shen;
- Negricea, Raluca;
- Li, Chi-Chung;
- Penuel, Elicia;
- Huang, Huang;
- Budde, L. Elizabeth
Publication type:
Article
Poster: ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S241, doi. 10.1016/S2152-2650(21)01516-0
By:
- Budde, Elizabeth;
- Ghosh, Nilanjan;
- Chavez, Julio;
- Lossos, Izidore S.;
- Mehta, Amitkumar;
- Dorritie, Kathleen;
- Kamdar, Manali;
- Negricea, Raluca;
- Song Pham;
- Hristopoulos, Maria;
- Ling-Yuh Huw;
- O'Hear, Carol;
- Yasuhiro Oki;
- To, Iris;
- Diefenbach, Catherine
Publication type:
Article
Managing Cytokine Release Syndrome and Neurotoxicity with Step-Up Dosing of Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S247, doi. 10.1016/j.clml.2019.07.151
By:
- Bartlett, Nancy L.;
- Sehn, Laurie H.;
- Assouline, Sarit;
- Bosch, Francesc;
- Diefenbach, Catherine M.;
- Flinn, Ian;
- Hong, Jung Yong;
- Kim, Wonseog S.;
- Matasar, Matthew;
- Nastoupil, Loretta;
- Schuster, Stephen J.;
- Shadman, Mazyar;
- Yoon, Sung-Soo;
- Bender, Brendan;
- Chu, Wayne;
- Hernandez, Genevive;
- Kwan, Antonia;
- McCall, Bruce;
- Sison, Iris;
- Wang, Cunlin
Publication type:
Article
Polatuzumab Vedotin: a New Target for B Cell Malignancies.
Published in:
Current Hematologic Malignancy Reports, 2020, v. 15, n. 2, p. 125, doi. 10.1007/s11899-020-00572-7
By:
- Choi, Yun;
- Diefenbach, Catherine S.
Publication type:
Article
XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes.
Published in:
Hematological Oncology, 2013, v. 31, p. 69, doi. 10.1002/hon.2070
By:
- Jagadeesh, Deepa;
- Diefenbach, Catherine;
- Evens, Andrew M.
Publication type:
Article
Hodgkin Lymphoma: Targeting the Tumor Microenvironment as a Therapeutic Strategy.
Published in:
Clinical Advances in Hematology & Oncology, 2015, v. 13, n. 8, p. 518
By:
- Montanari, Francesca;
- Diefenbach, Catherine S. M.
Publication type:
Article
Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies.
Published in:
Oncologist, 2023, v. 28, p. S14, doi. 10.1093/oncolo/oyad216.024
By:
- Jonasch, Eric;
- Call, Justin;
- Kambhampati, Swetha;
- Caimi, Paolo;
- Curti, Brendan;
- Diefenbach, Catherine;
- Heath, Elisabeth;
- Park, Steven;
- Kornblum, Noah;
- Li, Weidong;
- Reimers, Melissa;
- Spurgeon, Stephen;
- Vaishampayan, Ulka;
- Ye, Dingwei;
- Zhang, Li;
- Zhao, Weili;
- Chen, Zhu;
- Hunder, Naomi;
- Ma, Sharon;
- Song, Eric
Publication type:
Article
Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American Pathologists.
Published in:
Archives of Pathology & Laboratory Medicine, 2021, v. 145, n. 3, p. 269, doi. 10.5858/arpa.2020-0261-SA
By:
- Kroft, Steven H.;
- Sever, Cordelia E.;
- Bagg, Adam;
- Billman, Brooke;
- Diefenbach, Catherine;
- Dorfman, David M.;
- Finn, William G.;
- Gratzinger, Dita A.;
- Gregg, Patricia A.;
- Leonard, John P.;
- Smith, Sonali;
- Souter, Lesley;
- Weiss, Ronald L.;
- Ventura, Christina B.;
- Cheung, Matthew C.
Publication type:
Article
Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.
Published in:
2017
By:
- Diefenbach, Catherine S.;
- Connors, Joseph M.;
- Friedberg, Jonathan W.;
- Leonard, John P.;
- Kahl, Brad S.;
- Little, Richard F.;
- Baizer, Lawrence;
- Evens, Andrew M.;
- Hoppe, Richard T.;
- Kelly, Kara M.;
- Persky, Daniel O.;
- Younes, Anas;
- Kostakaglu, Lale;
- Bartlett, Nancy L.
Publication type:
journal article
Relapsed Hodgkin Lymphoma: Management Strategies.
Published in:
Current Hematologic Malignancy Reports, 2014, v. 9, n. 3, p. 284, doi. 10.1007/s11899-014-0220-7
By:
- Montanari, Francesca;
- Diefenbach, Catherine
Publication type:
Article

Found: 22